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An experimental (1H NMR) and theoretical (DFT) study of the ring–chain–ring isomerization of
3-(2-pyridyl)-[1,2,3]triazolo[1,5-a]pyrid-7-yl derivatives (A) into 6-{[1,2,3]triazolo[1,5-a]pyrid-3-yl}-2-pyridyl
derivatives (B) has been carried out. Based on the calculations, a mechanism of several steps will be proposed. The
experimental results as well as the calculations lead to the conclusion that the A–B ratio depends on the electronic
properties of the substituents.
Introduction
During our research on the chemistry of [1,2,3]triazolo[1,5-
a]pyridines 1, we were interested in synthesising 2-pyridyl-
[1,2,3]triazolo[1,5-a]pyrid-7-ylmethanones 3,1 to use them as
starting materials to prepare polypyridylcarbonylpyridines 6
and 7, polynitrogenated ligands able to make helicates, a
versatile family of supramolecular complexes.2 Compounds 3
can be synthesised from triazolopyridines 1a–d by regioselective
lithiation at −40 ◦C giving 2 and subsequent reaction with the
adequate electrophile.1,3,4 Reaction of 3 with N2H4 followed by
oxidation with MnO2, or with TsNHNH2 and aqueous sodium
hydroxide, gave the corresponding compounds 4.1 The new
ligands 6 and 7 can be accessed if the methodology summarised
above is applied several times, followed by triazolo ring opening
with loss of dinitrogen (Scheme 1). In this context we had
found an interesting structural feature for the compound so-
called 3c, (from now on 8). Its 1H NMR spectrum demonstrates
that it exists almost entirely as its isomer 9.1 To account for
this structure we assumed that, in solution, the ﬁrst formed
compound 8, a type A isomer, 3-(2-pyridyl)-[1,2,3]triazolo[1,5-
a]pyrid-7-yl derivative, is in equilibriumwith the diazo form; this
intermediate may undergo a new ring–chain isomerisation,5,6
Scheme 1 Reagents and conditions: (i) n-BuLi–toluene, −40 ◦C; (ii) 2-Py–CO2Et; (iii) N2H4; (iv) MnO2, Cl2CH2; (v) SeO2.
giving 9, a type B isomer, 6-{[1,2,3]triazolo[1,5-a]pyrid-3-yl}-2-
pyridyl derivative (Scheme 2).
Scheme 2
Probably the position of the A–B equilibrium depends on
some characteristics of the substituents. To verify this hypoth-
esis, we have carried out a 1H NMR study of a series of
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Table 1 1H NMR (in CDCl3). J values are given in Hertz (Hz)
R H4 H5 H6 H7 H3′ H4′ H5′ H6′ Other
1c H 8.69m 7.28dd 6.96dd 8.69m 8.27d 7.71dd 7.13dd 8.69m
Ref. 1 J1 = 9.0 J1 = 6.6 J = 8.0 J1 = 8.0 J1 = 5.1
J2 = 6.6 J2 = 7.3 J2 = 7.5 J2 = 7.5
9 2-PyCO 8.01d 7.10dd 6.95dd 8.65d 8.40d 7.92dd 7.98d 8.73d, H6′′
Ref. 1 J = 9.0 J1 = 9.0 J1 = 6.9 J = 6.9 J = 7.6 J1 = 7.6 J = 7.7 8.01d, H3′′
J2 = 6.0 J2 = 6.0 J2 = 7.7 7.85dd, H4′′
7.47dd, H5′′
10 SiMe3 8.61d 7.20dd 7.01d 8.27 7.69dd 7.10dd 8.57d 0.45s, 3CH3
Ref. 3 J = 9.1 J1 = 9.1 J = 6.6 J = 8.0 J1 = 8.0 J1 = 5.1 J = 5.1
J2 = 6.6 J2 = 7.6 J2 = 7.6
11 B(OR)2a 8.76d 7.26dd 7.46d 8.32d 7.72dd 7.14dd 8.59d 1.38s, 4CH3
Ref. 7 J = 8.9 J1 = 8.9 J = 6.6 J = 7.9 J1 = 7.7 J1 = 4.9 J = 4.9
J2 = 6.6 J2 = 7.7 J2 = 7.5
12 CH3CO 8.71d 7.46 dd 7.10ddd 8.80d 8.55dd 7.98–7.92 m 7.98–7.92 m 2.867s, CH3
J = 9 J1 = 9.0 J1 = 6.9 J = 6.9 J1 = 6.9
J2 = 6.9 J2 = 6.9 J2 = 2.4
J3 = 1.2
13 Br 8.65d 7.43dd 7.07dd 8.75d 8.28d 7.63dd 7.37dd
J = 9.0 J1 = 9.0 J1 = 7.2 J = 6.9 J = 7.8 J1 = 7.8 J = 8.1
J2 = 6.9 J2 = 6.6 J2 = 7.8
14 Cl 8.66d 7.40ddd 7.04ddd 8.72d 8.22d 7.70dd 7.19dd
J = 9 J1 = 8.7 J1 = 6.9 J = 6.9 J = 7.8 J1 = 7.8 J1 = 7.8
J2 = 6.9 J2 = 6.9 J2 = 7.8 J2 = 0.6
J3 = 0.9 J3 = 1.2
15 I 8.61d 7.43dd 7.07dd 8.76d 8.29d 7.38dd 7.61d
J = 9.0 J1 = 9.0 J1 = 6.9 J = 6.9 J = 7.8 J1 = 7.8 J = 7.8
J2 = 6.9 J2 = 6.9 J2 = 7.8
16 p-C6H4OMe 8.61d 6.99dd 7.34dd 8.70d 8.19d 7.76dd 7.56d 7.98d, 2H
J = 9.0 J1 = 9.0 J1 = 6.9 J = 6.9 J = 7.8 J1 = 7.8 J = 7.8 6.99d, 2H
J2 = 6.9 J2 = 6.9 J2 = 7.8 3.9s, OCH3
17 Me 75% 8.61d 7.32dd 6.89d 8.37d 7.78dd 7.20ddd 8.66d 2.92s, CH3
J = 9.0 J1 = 9.0 J = 6.9 J = 8.1 J1 = 7.8 J1 = 7.5 J = 4.8
J2 = 6.9 J2 = 7.8 J2 = 4.8
J3 = 0.9
18 Me 25% 8.76–8.72 m 7.38–7.73 m 7.04dd 8.76–8.72 m 8.13d 7.67d 7.07d 2.62s, CH3
J1 = 6.9 J = 7.8 J1 = 7.5 J = 7.8
J2 = 7.2 J2 = 7.8
a Pinacol ester.
pyridyltriazolo–pyridines 1c and 9–20 in order to study the
inﬂuence of the substituents on the equilibrium and on the ring–
chain isomerisation and hence on the structure of these products.
We have also carried out DFT/B3LYP/6-31G* calculations on
some of these compounds. We wish to report here the results of
this research.
Results and discussion
Trimethyl[3-(2-pyridyl)-[1,2,3]triazolo[1,5-a]pyrid-7-yl]silane
10, and 2-[3-(2-pyridyl)-7-[1,2,3]triazolo[1,5-a]pyridyl]-4,4,5,5-
tetramethyl[1,3,2]dioxaborolane 11, have been synthesised
previously.3,7 Pyridyltriazolopyridines 12–18 are new
compounds. Compound 12 was synthesised using the standard
procedure by lithiation of [1,2,3]triazolo[1,5-a]pyridines and
reaction with esters,1 using ethyl acetate as co-reagent. The
bromo- and chloro-derivatives 13 and 14 were prepared by
the method described by some of us for the halogenation
of 3-methyl-[1,2,3]triazolo[1,5-a]pyridine,8 lithiation reaction
followed by treatment with 1,2-dibromotetrachloroethane or
hexachloroethane respectively, using toluene as solvent in
the step of lithiation.4 The iodo-derivative 15 was prepared
by lithiation with LDA in THF,9 and then treatment
with I2. A Suzuki coupling reaction between 15 and 4-
methoxyphenylboronic acid, using dioxane as solvent and
Na2CO3 as base, gave the p-methoxyphenyl derivative 16 in
good yield. To synthesise compound 17 we used a general
procedure for the synthesis of triazolopyridines, reaction of
an acylpyridine with N2H4·H2O and, without isolation of the
corresponding hydrazone, oxidation with MnO2.10 The starting
material was 6-methyl-2-pyridyl-2-pyridylmethanone 21.
Table 1 reports the 1HNMRdata of series 1c, 9–18. The d and
J values for all of them prove that they have a pyridyltriazolo–
pyridine structure. In compounds 10 and 11, which contain a 3,7-
disubstituted triazolopyridine and a 2-substituted pyridine, the
presence of a proton with a coupling constant of J = 4.9–5.1 Hz
is signiﬁcant, corresponding to a H2 or H6 pyridine proton.
On the other hand, for compounds 9 and 12–16 which have a
3-substituted triazolopyridine and a 2,6-disubstituted pyridine,
there is always a H7 triazolopyridine proton present in these six
compounds as is proved by signals at d = 8.65–8.80 (d) with J =
6.9 Hz, characteristic of this type of protons. We can conclude
that those compounds that have electron-donating substituents
(10, 11) have the equilibrium shifted to the left, these are type A
isomers, while in those with electron-withdrawing substituents
(9, 12–16), the equilibrium is shifted to the right, being type B
isomers (Scheme 2). When the substituent is a methyl group, the
NMR spectrum corresponds to a mixture of both isomers 17
and 18, 75 : 25 in favour of 17.
In the parent compound 3-(2-pyridyl)-[1,2,3]triazolo[1,5-
a]pyridine 1c, this type of isomerization can take place, but it
would be a degenerate rearrangement and the product would
be structurally identical to the starting material. The existence
of degenerate isomers can be detected by use of isotopic labels,
thus we have incorporated deuterium in 1c after lithiation and
treatment with D2O. The spectrum of the deuterated compound
shows that a 50 : 50 mixture of 19 and its isomer 20 is present,
because all the signals are at the same d values and have exactly
the samemultiplicity as in the 1c spectrum (see Table 1), but only
the multiplets corresponding to H4, H7 and H6′, maintaining
the same appearance, have an integral value that shows that the
number of hydrogens being detected corresponds to 2.
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Fig. 1
In summary, we have proved that structures A and B are
in equilibrium (i.e., the isomerization barrier should be low)
and the A–B ratio depends on the electronic properties of the
R substituent. Electron-donating substituents [SiMe3, B(OR)2]
favour the A form, electron-withdrawing substituents [COMe,
Br, Cl, I, p-MeOPh] favour the B form, and only in the case
where R = Me are both forms present (75% of A, 25% of B).
Computational results
(a) Part concerning the reaction proﬁle (1c, Scheme 1, R′ = H)
The reaction path is more complex than was initially thought
(Fig. 1 and Scheme 3). In the case of 1c, the degenerate nature
of the process allows the representation of only one half of
the mechanism in Fig. 1 (in Scheme 3 it is complete). We will
distinguish three pathways:
The red pathway starts by a rotation of the pyridyl ring
about the C–C bond of the minimum M. It then goes through
the “orthogonal” transition state TS1 to a second minimum
R12, where both nitrogen atoms are on the same side. The
“planar” transition state (not represented) connects R12 with
its enantiomer (DE = 37.3 and DG = 38.8 kJ mol−1). From
R12 to R13 there is a TS of 96.4 kJ mol−1. From the reaction
intermediate R13, both minima M can be reached.
The blue pathway starts from M to RI4 (TS3, DG =
75.2 kJ mol−1) and RI4 with RI5 (TS, DG = 75.2 kJ mol−1).
From the reaction intermediate RI5, both minima M can be
reached.
The black pathway connects M with RI4 (TS3, DG =
75.2 kJ mol−1) and RI4 with RI3 through a second TS (TS4,
DG = 70.2 kJmol−1). The differences between the blue and black
pathways are very small (compare TS4 with TS5) and besides
the limiting step, common to both, is the transformation of M
into RI4 through TS3.
The red process corresponds to a ring–ring–chain–ring–ring
tautomerism while the black and blue ones are of a ring–chain–
chain–chain–ring type. In these last two cases, the higher barrier
involved, about 75 kJ mol−1, explains why in the cases of R = D
(19/20) and R = CH3 (17/18), an equilibrium was observed in
solution.
(b) Part concerning the A–B ratio
We have selected different R groups (Scheme 2), some of them
corresponding to those studied experimentally. In the case of
R = H, E = −642.960693 hartree. For the other substituents,
the difference in energy between the A and B isomers are
(in kJ mol−1): NO2 (−53.8), F (−40.7), Cl (−30.5), Br (−26.2),
OMe (−22.0), CN (−18.8), OH (−17.9), NMe2 (−17.8), COMe
(−14.0), CHO (−11.0), NH2 (−4.9), tBu (−2.3), CH3 (6.4),
SiH3 (15.1), SiMe3 (20.7) and B(OH)2 (29.2). The sign always
coincides with the isolated isomer. In the case of R = CH3,
6.4 kJ mol−1 corresponds to 93% of A and 7% of B, while the
experimental result is 75% A/25% B, which are in an acceptable
agreement.
If we situate the seven experimental values in a 10 to−10 scale,
to be consistent with the calculations it is necessary that Cl 14 =
−10, Br 13 = −9, COMe 12 = −5, H 1c = 0, Me 17/18 = 2,
SiMe3 10= 7 andB(OR)2 11= 10. These values are ordered from
electron-withdrawing to electron-releasing substituents but none
is linearly related to any Hammett or Taft coefﬁcients nor to
gas-phase basicity (PA) of 2-substituted pyridines (NIST data).
Only the combined use of rm, rp and MR (molar refractivity as
a steric coefﬁcient) yields an acceptable correlation coefﬁcient
(r2 = 0.955).
Experimental
Melting points were determined on a Koﬂer heated stage and
are uncorrected. NMR spectra were recorded on a Bruker AC
300MHz in CDCl3 as solvent. COSY experiments were done for
all compounds. HRMS (EI) determinations were made using a
VGAutospec Trio 1000 (Fisons). Infrared spectra were recorded
in KBr discs on a Bio-Rad FTS-7. All the lithiation reactions
were done under an inert atmosphere and in dry solvents.11
3-(2-Pyridyl)-[1,2,3]triazolo[1,5-a]pyridine 1c,
2-pyridyl-6-[1,2,3]triazolo[1,5-a]pyrid-3-yl-2-pyridylmethanone
9, trimethyl[3-(2-pyridyl)-[1,2,3]triazolo[1,5-a]pyrid-7-yl]silane
10, and 2-[3-(2-pyridyl)-7-[1,2,3]triazolo[1,5-a]pyridyl]-4,4,5,5-
tetramethyl[1,3,2]dioxaborolane 11
Prepared as described.3,7
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Scheme 3
3-(6-Acyl-2-pyridyl)-[1,2,3]triazolo[1,5-a]pyridine 12
To a solution of 3-(2-pyridyl)-[1,2,3]triazolo[1,5-a]pyridine 1c
(0.24 g, 1.22 mmol) in anhydrous toluene (20 mL) at −40 ◦C,
a solution of n-butyllithium in hexane (0.75 mL, 2.5 M) was
added with stirring. A deep red colour developed. The mixture
was kept at −40 ◦C (4 h). Treatment with dry ethyl acetate
(1 mL) produced a colour change to yellow. The mixture was
left at −40 ◦C (2 h) and allowed to warm to room temperature
overnight, and was then treated with a saturated solution of
ammonium chloride. The organic layer was separated and the
aqueous layer extracted with dichloromethane. After being
dried over anhydrous Na2SO4 and evaporation of the organic
solvents, the obtained residue was puriﬁed by chromatotron
with hexane and increasing polarity with ethyl acetate as eluent,
to obtain 3-(6-acyl-2-pyridyl)-[1,2,3]triazolo[1,5-a]pyridine 12
(20 mg, 8.6% over recovered starting material). Mp 189–
192 ◦C (CH2Cl2–hexane). HRMS found for M+ 238.0857;
C13H10N4O requires 238.0854. mmax (KBr)(cm−1) 3086, 3041,
2924, 2853, 1686, 1633, 1592, 1529. 13C NMR d(CDCl3) 199.74
(CO), 152.89 (C), 151.30 (C), 137.60 (CH), 136.67 (C), 132.00
(C), 126.92 (CH), 125.48 (CH), 123.81 (CH), 120.64 (CH),
119.87 (CH), 115.98 (CH), 26.26 (CH3). Then 3-(2-pyridyl)-
[1,2,3]triazolo[1,5-a]pyridine 1c (50 mg) was recovered, and
further elution gave 7,7′-bi[1,2,3]triazolo[1,5-a]pyridine (70mg).
Mp >350 ◦C, lit.3 >350 ◦C.
3-(6-Bromo-2-pyridyl)-[1,2,3]triazolo[1,5-a]pyridine 13
To a solution of 3-(2-pyridyl)-[1,2,3]triazolo[1,5-a]pyridine 1c
(0.48 g, 2.44 mmol) in anhydrous toluene (30 mL) at −40 ◦C, a
solution of n-butyllithium in hexane (1.5 mL, 2.5 M) was added
with stirring.Adeep red colour developed. Themixturewas kept
at −40 ◦C (4 h). Treatment with a dry toluene (5 mL) solution
of 1,2-dibromotetrachloroethane (2.0 g, 6.12 mmol) produced a
colour change to yellow. The mixture was left at −40 ◦C (2 h)
and allowed to warm to room temperature overnight, and was
then treated with a saturated solution of ammonium chloride.
The organic layer was separated and the aqueous layer extracted
withdichloromethane.After beingdriedover anhydrousNa2SO4
and evaporationof theorganic solvents, the obtained residuewas
puriﬁed by chromatotron with hexane–ethyl acetate (increasing
the polarity gradually) as eluent, to obtain 3-(6-bromo-2-
pyridyl)-[1,2,3]triazolo[1,5-a]pyridine 13 (50 mg, 10.5% based
on recovered starting material). Mp 199–201 ◦C (CH2Cl2–
hexane). HRMS found for M+ 273.9869/275.9851; C11H7BrN4
requires 273.9854/275.9833. mmax (KBr)(cm−1) 3105, 3044, 2926,
1633, 1587, 1555, 1536, 1031. 13C NMR d(CDCl3) 152.67 (C),
141.41 (C), 138.93 (CH), 135.80 (C), 132.10 (C), 126.98 (CH),
125.96 (CH), 125.23 (CH), 121.05 (CH), 118.74 (CH), 116.06
(CH). Then starting material 3-(2-pyridyl)-[1,2,3]triazolo[1,5-
a]pyridine 1c (140 mg) was eluted, and further elution gave
7,7′-bi[1,2,3]triazolo[1,5-a]pyridine (250 mg).3
3-(6-Chloro-2-pyridyl)-[1,2,3]triazolo[1,5-a]pyridine 14
To a solution of 3-(2-pyridyl)-[1,2,3]triazolo[1,5-a]pyridine 1c
(0.24 g, 1.22 mmol) in anhydrous toluene (20 mL) at −40 ◦C,
a solution of n-butyllithium in hexane (0.75 mL, 2.5 M) was
added with stirring. A deep red colour developed. The mixture
was kept at −40 ◦C (4 h). Treatment with a dry toluene solution
(5 mL) of hexachloroethane (0.72 g, 3.06 mmol) produced a
colour change to yellow. The mixture was left at −40 ◦C (2 h)
and allowed to warm to room temperature overnight, and was
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then treated with a saturated solution of ammonium chloride.
The organic layer was separated and the aqueous layer ex-
tracted with dichloromethane. After being dried over anhydrous
Na2SO4 and evaporation of the organic solvents, the obtained
residue was puriﬁed by chromatotron with hexane–ethyl acetate
(increasing the polarity gradually) as eluent, to obtain 3-(6-
chloro-2-pyridyl)-[1,2,3]triazolo[1,5-a]pyridine 14 (30 mg, 13%
over recovered starting material). Mp 178–180 ◦C (CH2Cl2–
hexane). HRMS found for M+ 230.0408/232.0379; C11H7ClN4
requires 230.0359/232.0329. mmax (KBr)(cm−1) 3105, 3046, 2923,
2853, 1635, 1590, 1527, 1036. 13C NMR d(CDCl3) 152.30 (C),
150.79 (C), 139.22 (CH), 132.13 (C), 131.77 (C), 126.94 (CH),
125.26 (CH), 122.13 (CH), 121.17 (CH), 118.46 (CH), 116.98
(CH). Then starting material 3-(2-pyridyl)-[1,2,3]triazolo[1,5-a]
pyridine 1c (45 mg) was eluted, and further elution gave 7,7′-bi
[1,2,3]triazolo[1,5-a]pyridine (100 mg).3
3-(6-Iodo-2-pyridyl)-[1,2,3]triazolo[1,5-a]pyridine 15
To a solution of LDA (1.2 eq.) in anhydrous THF (5 mL) at
−40 ◦C, a solution of 3-(2-pyridyl)-[1,2,3]triazolo[1,5-a]pyridine
1c (0.5 g, 2.6 mmol) in THF (5 mL, 2.5 M) was added with
stirring after 30 min. A deep red colour developed. The mixture
was kept at −40 ◦C (4 h) and was then treated with a dry THF
solution (5 mL) of iodine (1.2 eq.). The mixture was allowed to
warm to room temperature overnight, and was then treated with
a saturated solution of ammonium chloride and extracted with
dichloromethane. The organic layer was washed with a solution
of NaHSO3 10%, a saturated solution of NaCl and water. After
being dried over anhydrous Na2SO4 and evaporation of the
organic solvents, the obtained solid residue (760mg)was puriﬁed
by silica column chromatography with hexane–ethyl acetate
(increasing the polarity gradually) as eluent, to obtain 3-(6-iodo-
2-pyridyl)-[1,2,3]triazolo[1,5-a]pyridine 15 (415 mg, 1.3 mmol,
49%). Mp 193–195 ◦C (EtOAc–hexane). HRMS found for M+
321.9684; C11H7IN4 requires 321.9715. mmax (KBr)(cm−1) 3103,
3041, 1633, 1583, 1536, 663. 13C NMR d(CDCl3) 153.32 (C),
138.45 (CH), 136.24 (C), 133.09 (CH), 132.54 (C), 127.39 (CH),
125.67 (CH), 121.33 (CH), 119.54 (CH), 117.70 (C), 116.49
(CH).
3-[6-(4-Methoxyphenyl-2-pyridyl)]-[1,2,3]triazolo[1,5-a] pyridine
16
To a mixture of 3-(6-iodo-2-pyridyl)-[1,2,3]triazolo[1,5-a]-
pyridine 15 (160 mg, 0.75 mmol), 4-methoxyphenylboronic acid
(130 mg, 0.75 mmol) and Pd(PPh3)4 (6%), dioxane was added
(15 mL) with stirring. The mixture was kept at −40 ◦C (4 h)
and was then treated with a dry THF solution (5 mL) of iodine
(1.2 eq.). The mixture was heated to 85 ◦C with stirring for 8 h,
and was then allowed to warm to room temperature, water was
added and the mixture was extracted with dichloromethane.
The organic layer was dried over anhydrous Na2SO4 and the
organic solvents evaporated; the obtained solid residue (270mg)
was puriﬁed by silica column chromatography with hexane–
ethyl acetate (increasing the polarity gradually) as eluent,
to obtain 3-[6-(4-methoxyphenyl-2-pyridyl)-[1,2,3]triazolo[1,5-
a]pyridine 16 (128mg, 0.4mmol, 80%).Mp213–215 ◦C(EtOAc–
hexane). HRMS found for M+ 302.1112; C18H14N4O requires
302.1168. mmax (KBr)(cm−1) 3089, 2926, 1593, 1561, 1244, 1118.
13C NMR d(CDCl3) 160.87 (C), 156.94 (C), 152.02 (C), 138.18
(C), 137.89 (CH), 132.72 (C), 132.47 (C), 128.56 (CH), 126.80
(CH), 125.67 (CH), 121.82 (CH), 118.62 (CH), 118.52 (CH),
116.30 (CH), 55.59 (CH3).
6-Methyl-2-pyridyl-2-pyridylmethanone 21
To a solution of 2-bromo-6-methylpyridine (0.2 mL, 1.79 mmol)
in dry ether (20 mL) at −78 ◦C under N2, a solution of n-
butyllithium in hexane (0.83 mL, 2.5 M) was added gradually.
The mixture was kept at −78 ◦C (75 min), and then was
treated with a dry ether solution of ethyl picolinate (0.28 mL),
was kept at −78 ◦C (3 h) and was allowed to warm to
room temperature overnight. The reaction mixture was treated
with a saturated solution of ammonium chloride, the organic
phase was separated and the aqueous phase was extracted with
dichloromethane. The combined organic phases were dried with
Na2SO4 and concentrated. The residue was submitted to column
chromatography with hexane–ethyl acetate (2 : 1) as eluent
obtaining 6-methyl-2-pyridyl-2-pyridylmethanone 21 (80 mg,
23%).12
7-Methyl-3-(2-pyridyl)-[1,2,3]triazolo[1,5-a]pyridine 17 and
3-(6-methyl-2-pyridyl)-[1,2,3]triazolo[1,5-a]pyridine 18
Amixture of 6-methyl-2-pyridyl-2-pyridylmethanone 21 (80mg)
and hydrazine monohydrate (2.5 mL) was heated to 100 ◦C for
2 h. The reaction mixture was treated with a solution of sodium
hydroxide (5 mL, 30%) and then was extracted with CH2Cl2.
After evaporation of the organic solvent, the residue (68mg) was
reﬂuxed in dried chloroform with activated manganese dioxide
(150 mg) for 15 h. The hot solution was ﬁltered over celite.
The ﬁltrate was concentrated (75 mg). The crude mixture was
puriﬁed by chromatotron with hexane–ethyl acetate (increasing
the polarity gradually) as eluent, to obtain an isomeric mixture
of 7-methyl-3-(2-pyridyl)-[1,2,3]triazolo[1,5-a]pyridine (75%) 17
and 3-(6-methyl-2-pyridyl)-[1,2,3]triazolo[1,5-a]pyridine (25%)
18 (25 mg, 42.8%). Mp 108–110 ◦C (CH2Cl2–hexane). HRMS
found for M+ 210.0889; C12H10N4 requires 210.0905. mmax
(KBr)(cm−1) 3053, 2959, 2921, 1641, 1602, 1551, 1535. 13CNMR
d(CDCl3) for 17 152.21 (C), 149.20 (CH), 137.58 (C), 136.48
(CH), 135.79 (C), 132.19 (C), 126.50 (CH), 121.78 (CH), 120.44
(CH), 118.54 (CH), 114.77 (CH), 17.42 (CH3), for 18 136.82
(CH), 126.07 (CH), 125.09 (CH), 121.49 (CH), 121.38 (CH),
117.30 (CH), 115.74 (CH), 24.59 (CH3). Then starting material
(25 mg) was eluted.
Computational details
Geometries of the stationary structures 10a and 13a were
fully optimised at the B3LYP theoretical level,13,14 with the 6-
31G* basis set15 as implemented in the Gaussian 98 program.16
Harmonic frequency calculations17 veriﬁed the nature of the
stationary points as minima (all real frequencies) and TS (only
one imaginary frequency).
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